Paul Murray Wart Remover

Nom de l'organisation

PK Benelux BV

SRN

NL-MF-000006672

Statut du fabricant

Actif

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW999

  Not for pregnant women or while breastfeeding Not for children aged 3 years and younger Do not use Wart Away: • If you are oversensitive to one or more of the ingredients; • In the face (the fluid should never make contact with the eyes or the mucous membrane in the nose or mouth); • For genital warts or in the genital area; • On birthmarks, water warts, open wounds, moles, naevus, senile (brown) warts, plantar warts, darkly coloured, hairy or strange looking warts; • On red, irritated or infected warts; • Immediately after a surgical removal of warts, freezing of warts (cryotherapy) or a laser treatment. This particularly applies when the skin is red or painful after the treatment. In this case you will have to wait for at least 4 weeks, until the redness or inflammation of the skin has fully disappeared. Only then you can start using Wart Away; • During pregnancy or while breastfeeding; • Do not use on warts which occur completely or partly underneath the nail. • Do not use on warts that occur completely or partially on the sole of the feet (plantar warts). Use in combination with drugs: As far as we know, there are no interactions with drugs. Possible side effects: Wart Away may cause some side effects, although not everyone will experience these side effects. The side effects that could occur when using Wart Away are: irritated skin, burning sensation, skin redness or oversensitivity reactions. If any of these side effects becomes serious, or if you notice any side effects not listed in these instructions for use, please consult your doctor or pharmacist.

Marché principal en Allemagne ; disponible dans 1 pays au total.

Dénomination commerciale

Paul Murray Wart Remover

Code d'UDI-DI

D-SA380183

Basic UDI-DI

B-SA380183

Numéro de référence/catalogue

SA3801

Entité d'attribution

EUDAMED

Catégorie de risque

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

To treat nongenital warts (Verruca vulgaris) due to the mechanical destruction of wart tissue

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

D-SA380183

La génération de DataMatrix prend en charge les IUD émis par GS1. La prise en charge HIBCC / ICCBBA arrive bientôt.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• M9002PROTECTIVE DEVICES, LUBRICANTS AND SOOTHING DEVICES (SPRAYS, GELS, FLUIDS AND CREAMS)